TUG1 Suppression Boosts Immunity and Lenvatinib in Liver Cancer
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues ...
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues ...
In the realm of oncology, the quest for precision medicine has led to intriguing advancements that hold promise for cancer ...
In the evolving field of oncology, new discoveries are continually reshaping our understanding of how tumors interact with the immune ...
In an era marked by relentless pursuit of novel cancer therapies, the spotlight has turned toward natural compounds with groundbreaking ...
In a groundbreaking advancement for liver cancer treatment, researchers from the University of Birmingham have demonstrated that a novel dendritic ...
In a groundbreaking multicentric study conducted across two leading cancer centers in India, researchers have unveiled critical insights into the ...
In recent years, the medicinal properties of Lycium barbarum, commonly known as goji berry, have captured significant attention within the ...
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, poses a formidable challenge in oncology due to its aggressive ...
In the high-stakes arena of liver cancer surgery, the ability to predict post-operative complications is not just advantageous—it can be ...
Hepatocellular Carcinoma and the Expanding Role of Liver Transplantation: A Comprehensive Update Hepatocellular carcinoma (HCC) stands as the predominant form ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine